Abstract: Long-term outcome of percutaneous coronary intervention (PCI) compared to coronary artery bypass grafting (CABG) for unprotected left main coronary artery disease (ULMCAD) remain to be investigated. We identified 1005 patients with ULMCAD among 15939 patients with first coronary revascularization enrolled in the CREDO-Kyoto PCI/CABG registry cohort-2. Cumulative 3-year incidence of a composite of death/myocardial infarction (MI)/stroke was significantly higher in the PCI group than in the CABG group (22.7% vs.
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14.8%, log rank p=0.0006). However, the adjusted outcome was not different between the PCI and CABG groups (hazard ratio (HR): 1.30, 95% confidence interval (C.I): 0.79-2.15, p=0.30).
The stratified analysis using the SYNTAX score demonstrated that risk for a composite of death/MI/stroke was not different between the 2 treatment groups in patients with low (<23) and intermediate SYNTAX score (23-33) (adjusted HR 1.70, 95% CI: 0.77-3.76, p=0.19 and adjusted HR 0.86, 95% CI: 0.37-1.99, p=0.72, respectively), while in patients with high SYNTAX score (≥ 33), it was significantly higher after PCI than after CABG (adjusted HR 2.61, 95% CI: 1.32-5. 16 , p=0.006). In conclusions, the risk of PCI for serious adverse events seemed to be comparable to that after CABG in ULMCAD patients with low or intermediate SYNTAX score, while PCI as compared with CABG was associated with a higher risk for serious adverse events in patients with high SYNTAX score.
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Text
In recent years, several observational studies reported favorable clinical outcomes of percutaneous coronary intervention (PCI) using drug eluting stent (DES) in patients with unprotected left main coronary artery disease (ULMCAD) [1] [2] [3] .
SYNTAX (Synergy Between
Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) randomized trial reported comparable safety and efficacy outcomes of PCI relative to coronary artery bypass grafting (CABG) in the left main disease subset [4] [5] [6] . Reflecting these study results, updated clinical guidelines for ULMCAD regarded PCI as an alternative to CABG in patients with less complex coronary anatomy or in patients with high surgical risk 7, 8 . However, number of patients enrolled in these trials was still insufficient in drawing definitive conclusions on the role of PCI in treating patients with ULMCAD. Therefore, we evaluated the long-term clinical outcome of PCI relative to CABG and the utility of the SYNTAX score for risk stratification in patients with ULMCAD in a large observational database in Japan.
Methods
The CREDO-Kyoto (Coronary REvascularization Demonstrating Outcome Study in Kyoto) PCI/CABG registry cohort-2 is a physician-initiated, non-company sponsored, multi-center registry that enrolled consecutive patients undergoing first coronary revascularization among 26 centers in Japan between January 2005 and December 2007. The relevant ethics committees in all 26 participating centers (Supplemental Appendix A) approved the research protocol. Because of retrospective enrollment, written informed consents from the patients were waived. However, patients who refused participation in the study when contacted for follow-up were excluded.
The study design and patient enrollment in the registry have been described in detail previously 9 . Among 15939 patients enrolled in the registry, the study population for the current pre-specified sub-analysis of the CREDO-Kyoto PCI/CABG registry cohort-2 consisted of 1005 patients with ULMCAD (PCI: 365 patients, and CABG: 640 patients), excluding those patients with refusal for study participation, concomitant non-coronary surgery and acute myocardial infarction ( Figure 1 ).
Demographic, angiographic, and procedural data were collected from hospital charts according to pre-specified definitions by experienced research coordinators in the independent research organization (Research Institute for Production Development, Kyoto, Japan) (Supplemental Appendix B). Patients with ULMCAD were identified using the angiographic information recorded in their hospital charts. Therefore, the current study population included those patients in whom PCI was not attempted for the left main coronary artery lesions based on clinical judgments. The definitions for clinical characteristics are described in the Supplemental
Text.
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The SYNTAX score was calculated using the SYNTAX score calculator (available at http://www.syntaxscore.com) by a dedicated SYNTAX score committee (Supplemental Appendix C) in a blinded fashion to the clinical data. Intra-and inter-observer variabilities of the SYNTAX score calculation in our group were previously reported 10 . The cutoff values for the SYNTAX score tertiles (low-score: <23, intermediate-score: 23-33, and high-score: ≥33)
were defined according to the analysis in the SYNTAX trial 4, 5 .
The primary outcome measure for the current analysis was defined as a composite of all-cause death, myocardial infarction (MI), and stroke. Other pre-specified endpoints included all-cause death, cardiac death, MI, stroke, and coronary revascularization. Death was regarded as cardiac in origin unless obvious non-cardiac causes could be identified. Any death during the index hospitalization for coronary revascularization was regarded as cardiac death. MI was defined according to the definition in the Arterial Revascularization Therapy Study 11 . Stroke was defined as ischemic or hemorrhagic stroke requiring hospitalization with symptoms lasting >24 hours. Coronary revascularization was defined as either PCI or CABG for any reasons.
Scheduled staged coronary revascularization procedures performed within 3 months of the initial procedure were not regarded as follow-up events, but were included in the index procedure. Categorical variables were presented as number and percentage and were compared with the chi-square test. Continuous variables were expressed as mean value ± standard deviation (SD) or median with Interquartile range (IQR). Continuous variables were compared using the Student's t-test or Wilcoxon rank sum test based on their distributions.
Cumulative incidence was estimated by the Kaplan-Meier method and differences were assessed using the log-rank test. The effects of PCI relative to CABG for individual endpoints were expressed as hazard ratios (HR) with 95% confidence intervals (CI). In the entire study population, HR was estimated using the non-parsimonious multivariable Cox proportional hazard models adjusted for the 30 clinically relevant factors in Table 1 , which was consistent with previous reports from the current registry. Continuous variables were dichotomized using clinically meaningful reference values or median values. Proportional hazard assumptions for potential independent risk-adjusting variables were assessed on log (time) versus log [-log (survival)] plots stratified by the variable, and the assumptions were verified as acceptable for all variables. We incorporated the 26 participating centers in the Cox proportional hazard models as the stratification variable.
The unadjusted and adjusted risks of PCI relative to CABG for the primary outcome measure were evaluated in each SYNTAX score category as a subgroup analysis to assess utility of the SYNTAX score for risk stratification. In addition to the modes of coronary revascularization (PCI versus CABG), 4 variables with p value <0.05 in the previously described full model (Age >= 75 years, Estimated glomerular filtration rate <30 mL/min/1.73m 2 , without hemodialysis, Hemodialysis, and Proton pump inhibitors) were included in the multivariable models for the subgroup analysis reflecting our preference for parsimonious models to avoid over-fitting. 
Results
Patients in the PCI group were older, and more often had malignancy and severe mitral regurgitation, while patients in the CABG group more often had diabetes on insulin therapy, and thrombocytopenia ( Table 1 ).
The CABG group included more patients with complex coronary anatomy and greater numbers of target lesions or anastomoses ( Table 1 ). The SYNTAX scores were available in 932 patients (92.7%). The median SYNTAX score was significantly greater in the CABG group than in the PCI group. Stents were used in 98% of the patients in the PCI group, and at least one DES was used in 78% of the patients. In the PCI group, PCI targeting for ULMCA lesion was performed in 306 patients (83.4%), in whom left main distal bifurcation was involved in 210 patients (68.6%) and DES was used for the left main lesion in 209 patients (68.3%). At least one internal thoracic artery was used in 98.3% of patients in the CABG group, and the prevalence of off-pump CABG was high (64.7%). Baseline medications were significantly different in several aspects between the two groups ( Table 1 ).
The cumulative 3-year incidence of the primary outcome measure (death/MI/stroke) in the PCI group was significantly higher than that in the CABG group (22.7% vs. 14.8%, log rank p=0.0006) (Figure 2A ). However, after adjusting for potential confounders, the risk of PCI relative to CABG for the primary outcome measure was not significantly different (adjusted HR: 1.30, 95% C.I: 0.79-2.15, p=0.30) ( Table 2) . Regarding survival outcome, the cumulative 3-year incidence of all-cause death and cardiac death were higher in the PCI group than that in the CABG group (13.6% vs. 9.2%, log rank p=0.01, and 7.4% vs. 3.7%, log rank p=0.005, respectively) ( Figure 2B , and 2C). However, the adjusted risk for all-cause death and cardiac death were not different between the 2 groups (adjusted HR: 0.79, 95% C.I: 0.40-1.57, p=0.50, and adjusted HR: 1.80, 95% C.I: 0.64-5.09, p=0.27, respectively) ( Table 2 ). The cumulative 3-year incidence of MI was significantly higher in the PCI group compared to the CABG group (5.5% vs. 2.3%, log rank p=0.003) ( Figure 2D ). However, the adjusted risk of PCI relative to CABG for MI was not significantly different (adjusted HR: 2.47, 95% C.I: 0.81-7.54, p=0.11), although the point estimate strongly favored CABG ( Table 2 ). The cumulative 3-year incidence of definite ST in the PCI group was low (1.5%). The risk for stroke was not different between the two groups (6.6% vs. 5.5%, log rank p=0.43, adjusted HR: 0.79, 95% C.I: 0.30-2.08, p=0.63) ( Figure 2E , and Table 2 ). PCI was associated with a markedly higher risk for any coronary revascularization compared to CABG (43.4% vs. 11.2%, log rank p<0.0001, adjusted HR: 5.83, 95% C.I: 3.74-9.09, p<0.0001) ( Figure 2F , and Table 2 ).
Clinical outcome was compared between the PCI and CABG groups among the 3 categories of coronary anatomic complexities stratified by the SYNTAX score. The cumulative 3-year incidences of the primary outcome measure were not different between the PCI and CABG groups in patients with low and intermediate SYNTAX score (22.8% vs. 14.7%, log rank p=0.08, and 19.5% vs. 14.3%, log rank p=0.21). However, the cumulative 3-year incidence of the primary outcome measure was markedly higher in the PCI group than that in the CABG group in patients with high SYNTAX score (27.4% vs. 16.8%, log rank p=0.006) (Figure 3 ).
After adjustment for potential confounders, the risk of PCI relative to CABG for the primary outcome measure remained significantly higher in patients with high SYNTAX score (adjusted 
Discussion
The main findings in the current study were as follows; (1) However, the number of patients studied was still insufficient to advocate widespread use of PCI in ULMCAD patients with less complex coronary anatomy. The results of the EXCEL trial, which is an ongoing randomized trial comparing PCI using everolimus-eluting stents with CABG in 2600 ULMCAD patients with SYNTAX score <33, would provide further guidance for PCI use in this important subset of patients.
There are several important limitations in this study. First and most importantly, observational study design precluded definitive conclusions in terms of superiority of either PCI or CABG due to selection bias and unmeasured confounders. Since CABG had been considered to be the gold standard for ULMCAD patients, selection bias could be greater in patients with ULMCAD as compared with other subsets of severe coronary artery disease such as triple vessel coronary artery disease. Therefore, the results in the current study should be interpreted very carefully. Furthermore, the results from the SYNTAX subgroup analyses should be regarded as hypothesis generating. Second, number of patients enrolled was still small and SYNTAX score data were not available for all patients. Third, the duration of follow-up might not be sufficient to evaluate long-term outcome of coronary revascularization. Finally, we did not exclude those patients in whom PCI was not attempted for the left main coronary artery lesions based on clinical judgments. The current study population might include patients with less severe left main coronary artery lesions in both PCI and CABG groups.
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CABG=coronary artery bypass grafting, MI=myocardial infarction, PCI=percutaneous coronary intervention, and SYNTAX=SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery. 
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